Búsqueda | Portal de Búsqueda de la BVS España

1.

Impact of the first wave of the COVID-19 pandemic on the treatment of psoriasis with systemic therapies in France: Results from the PSOBIOTEQ cohort.

Arlegui, H; Mahé, E; Richard, M-A; De Rycke, Y; Viguier, M; Beylot-Barry, M; Dupuy, A; Beneton, N; Joly, P; Jullien, D; Bachelez, H; Sbidian, É; Chosidow, O; Paul, C; Tubach, F.

Ann Dermatol Venereol; 150(2): 101-108, 2023 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-36914553

2.

Long-term safety of risankizumab from 17 clinical trials in patients with moderate-to-severe plaque psoriasis.

Gordon, K B; Lebwohl, M; Papp, K A; Bachelez, H; Wu, J J; Langley, R G; Blauvelt, A; Kaplan, B; Shah, M; Zhao, Y; Sinvhal, R; Reich, K.

Br J Dermatol; 186(3): 466-475, 2022 03.

Artículo en Inglés | MEDLINE | ID: mdl-34652810

3.

Palmoplantar pustulosis and acrodermatitis continua of Hallopeau: demographic and clinical comparative study in a large multicentre cohort.

Assan, F; Husson, B; Hegazy, S; Seneschal, J; Aubin, F; Mahé, E; Jullien, D; Sbidian, E; D'Incan, M; Conrad, C; Brenaut, E; Girard, C; Richard, M A; Bachelez, H; Viguier, M.

J Eur Acad Dermatol Venereol; 36(9): 1578-1583, 2022 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-35366356

4.

Switches between biologics in patients with moderate-to-severe psoriasis: results from the French cohort PSOBIOTEQ.

Curmin, R; Guillo, S; De Rycke, Y; Bachelez, H; Beylot-Barry, M; Beneton, N; Chosidow, O; Dupuy, A; Joly, P; Jullien, D; Richard, M A; Viguier, M; Sbidian, E; Paul, C; Mahé, E; Tubach, F.

J Eur Acad Dermatol Venereol; 36(11): 2101-2112, 2022 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-35793473

5.

Children with psoriasis and COVID-19: factors associated with an unfavourable COVID-19 course, and the impact of infection on disease progression (Chi-PsoCov registry).

Zitouni, J; Bursztejn, A-C; Belloni Fortina, A; Beauchet, A; Di Lernia, V; Lesiak, A; Thomas, J; Topkarci, Z; Murashkin, N; Brzezinski, P; Torres, T; Chiriac, A; Luca, C; McPherson, T; Akinde, M; Maruani, A; Epishev, R; Vidaurri de la Cruz, H; Luna, P C; Amy de la Bretêque, M; Lasek, A; Bourrat, E; Bachelerie, M; Mallet, S; Steff, M; Bellissen, A; Neri, I; Zafiriou, E; van den Reek, J M P A; Sonkoly, E; Mahil, S K; Smith, C H; Flohr, C; Bachelez, H; Mahé, E.

J Eur Acad Dermatol Venereol; 36(11): 2076-2086, 2022 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-35748102

6.

Type I interferon response and vascular alteration in chilblain-like lesions during the COVID-19 outbreak.

Frumholtz, L; Bouaziz, J-D; Battistella, M; Hadjadj, J; Chocron, R; Bengoufa, D; Le Buanec, H; Barnabei, L; Meynier, S; Schwartz, O; Grzelak, L; Smith, N; Charbit, B; Duffy, D; Yatim, N; Calugareanu, A; Philippe, A; Guerin, C L; Joly, B; Siguret, V; Jaume, L; Bachelez, H; Bagot, M; Rieux-Laucat, F; Maylin, S; Legoff, J; Delaugerre, C; Gendron, N; Smadja, D M; Cassius, C.

Br J Dermatol; 185(6): 1176-1185, 2021 12.

Artículo en Inglés | MEDLINE | ID: mdl-34611893

7.

Risk-mitigating behaviours in people with inflammatory skin and joint disease during the COVID-19 pandemic differ by treatment type: a cross-sectional patient survey.

Mahil, S K; Yates, M; Langan, S M; Yiu, Z Z N; Tsakok, T; Dand, N; Mason, K J; McAteer, H; Meynell, F; Coker, B; Vincent, A; Urmston, D; Vesty, A; Kelly, J; Lancelot, C; Moorhead, L; Bachelez, H; Bruce, I N; Capon, F; Contreras, C R; Cope, A P; De La Cruz, C; Di Meglio, P; Gisondi, P; Hyrich, K; Jullien, D; Lambert, J; Marzo-Ortega, H; McInnes, I; Naldi, L; Norton, S; Puig, L; Sengupta, R; Spuls, P; Torres, T; Warren, R B; Waweru, H; Weinman, J; Griffiths, C E M; Barker, J N; Brown, M A; Galloway, J B; Smith, C H.

Br J Dermatol; 185(1): 80-90, 2021 07.

Artículo en Inglés | MEDLINE | ID: mdl-33368145

8.

Out-of-pocket expenditures in France to manage psoriasis in adult patients: results from an observational, cross-sectional, non-comparative, multicentre study.

Richard, M-A; Paul, C; De Pouvourville, G; Jullien, D; Mahe, E; Bachelez, H; Seneschal, J; Misery, L; Aubert, R; Reguiai, Z; Shourick, J; Taieb, C; Joly, P; Ezzedine, K.

J Eur Acad Dermatol Venereol; 35(4): 912-918, 2021 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-33073410

9.

Efficacy and safety of TNF blockers and of ustekinumab in palmoplantar pustulosis and in acrodermatitis continua of Hallopeau.

Husson, B; Barbe, C; Hegazy, S; Seneschal, J; Aubin, F; Mahé, E; Jullien, D; Sbidian, E; D'Incan, M; Conrad, C; Brenaut, E; Girard, C; Richard, M A; Bachelez, H; Viguier, M.

J Eur Acad Dermatol Venereol; 34(10): 2330-2338, 2020 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-32030802

10.

Users of biologics in clinical practice: would they be eligible for phase III clinical studies? Cohort Study in the French Psoriasis Registry PSOBIOTEQ.

Masson Regnault, M; Castañeda-Sanabria, J; Diep Tran, M H T; Beylot-Barry, M; Bachelez, H; Beneton, N; Chosidow, O; Dupuy, A; Joly, P; Jullien, D; Mahé, E; Richard, M-A; Viguier, M; Tubach, F; Sbidian, E; Paul, C.

J Eur Acad Dermatol Venereol; 34(2): 293-300, 2020 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-31419355

11.

Benefit-risk profile of tofacitinib in patients with moderate-to-severe chronic plaque psoriasis: pooled analysis across six clinical trials.

Strober, B E; Gottlieb, A B; van de Kerkhof, P C M; Puig, L; Bachelez, H; Chouela, E; Imafuku, S; Thaçi, D; Tan, H; Valdez, H; Gupta, P; Kaur, M; Frajzyngier, V; Wolk, R.

Br J Dermatol; 180(1): 67-75, 2019 01.

Artículo en Inglés | MEDLINE | ID: mdl-30188571

12.

Tofacitinib efficacy, patient-reported outcomes and safety in patients with psoriasis and a medical history of psoriatic arthritis: Pooled analysis of two Phase III studies.

Bachelez, H; Griffiths, C E M; Papp, K A; Hall, S; Merola, J F; Feldman, S R; Khraishi, M; Tan, H; Fallon, L; Cappelleri, J C; Bushmakin, A G; Young, P.

J Eur Acad Dermatol Venereol; 2024 Jan 11.

Artículo en Inglés | MEDLINE | ID: mdl-38213065

13.

Pustular psoriasis and related pustular skin diseases.

Bachelez, H.

Br J Dermatol; 178(3): 614-618, 2018 03.

Artículo en Inglés | MEDLINE | ID: mdl-29333670

14.

Trends in hospitalization rates for psoriasis flares since the introduction of biologics: a time series in France between 2005 and 2015.

Polivka, L; Oubaya, N; Bachelez, H; Paul, C; Richard, M A; Beylot-Barry, M; Schmutz, J L; Beneton, N; Mahé, E; Viguier, M; Chosidow, O; Canoui-Poitrine, F; Sbidian, E.

J Eur Acad Dermatol Venereol; 32(11): 1920-1929, 2018 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-29729123

15.

Clinical and epidemiological features of psoriasis exacerbations in children with SARS-CoV-2 infection.

Skrek, S; Di Lernia, V; Beauchet, A; Bursztejn, A-C; Belloni Fortina, A; Lesiak, A; Thomas, J; Brzezinski, P; Topkarci, Z; Murashkin, N; Torres, T; Epishev, R; Chiriac, A; McPherson, T; Akinde, M; Maruani, A; Luna, P C; Vidaurri de la Cruz, H; Mallet, S; Leducq, S; Sergeant, M; Zitouni, J; Mahil, S K; Smith, C H; Flohr, C; Bachelez, H; Mahé, E.

J Eur Acad Dermatol Venereol; 37(10): e1192-e1195, 2023 10.

Artículo en Inglés | MEDLINE | ID: mdl-37326146

16.

Clinical similarity of the biosimilar ABP 501 compared with adalimumab after single transition: long-term results from a randomized controlled, double-blind, 52-week, phase III trial in patients with moderate-to-severe plaque psoriasis.

Papp, K; Bachelez, H; Costanzo, A; Foley, P; Gooderham, M; Kaur, P; Philipp, S; Spelman, L; Zhang, N; Strober, B.

Br J Dermatol; 177(6): 1562-1574, 2017 12.

Artículo en Inglés | MEDLINE | ID: mdl-28755394

17.

A Topical Treatment Optimization Programme (TTOP) improves clinical outcome for calcipotriol/betamethasone gel in psoriasis: results of a 64-week multinational randomized phase IV study in 1790 patients (PSO-TOP).

Reich, K; Zschocke, I; Bachelez, H; de Jong, E M G J; Gisondi, P; Puig, L; Warren, R B; Ortland, C; Mrowietz, U.

Br J Dermatol; 177(1): 197-205, 2017 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-28301043

18.

Infections from seven clinical trials of ixekizumab, an anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriasis.

Papp, K A; Bachelez, H; Blauvelt, A; Winthrop, K L; Romiti, R; Ohtsuki, M; Acharya, N; Braun, D K; Mallbris, L; Zhao, F; Xu, W; Walls, C D; Strober, B.

Br J Dermatol; 177(6): 1537-1551, 2017 12.

Artículo en Inglés | MEDLINE | ID: mdl-28600810

19.

A European subset analysis from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis shows country-specific features: results from psoriasis patients in Spain.

Puig, L; van de Kerkhof, P C M; Reich, K; Bachelez, H; Barker, J; Girolomoni, G; Paul, C.

J Eur Acad Dermatol Venereol; 31(7): 1176-1182, 2017 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-28271561

20.

The role of IL-23 and the IL-23/T_H 17 immune axis in the pathogenesis and treatment of psoriasis.

Girolomoni, G; Strohal, R; Puig, L; Bachelez, H; Barker, J; Boehncke, W H; Prinz, J C.

J Eur Acad Dermatol Venereol; 31(10): 1616-1626, 2017 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-28653490

Portal de Búsqueda de la BVS España

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar: